Repeat-mediated genetic and epigenetic changes at the FMR1 locus in the Fragile X-related disorders

Frontiers in Genetics

Volumn 5, Issue JUL, 2014, Pages

  Usdin, Karen ^a   Hayward, Bruce E ^a   Kumari, Daman ^a   Lokanga, Rachel A ^a   Sciascia, Nicholas ^a   Zhao, Xiao Nan ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

Fragile X syndrome (FXS); Fragile X related disorders; FX associated primary ovarian insufficiency (FXPOI); FX associated tremor ataxia syndrome (FXTAS); Repeat expansion disease

Indexed keywords

FRAGILE X MENTAL RETARDATION PROTEIN; OKAZAKI FRAGMENT;

CHROMOSOME FRAGILITY; DNA METHYLATION; DNA REPLICATION ORIGIN; EPIGENETICS; FRAGILE X SYNDROME; GAIN OF FUNCTION MUTATION; GENE EXPRESSION; GENE MUTATION; GENE SILENCING; GENETIC TRAIT; HUMAN; MISMATCH REPAIR; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OXIDATIVE STRESS; PREMATURE OVARIAN FAILURE; REVIEW;

EID: 84906262080     PISSN: None     EISSN: 16648021     Source Type: Journal    
DOI: 10.3389/fgene.2014.00226     Document Type: Review

References (235)

1. Aamann, M. D., Muftuoglu, M., Bohr, V. A., and Stevnsner, T. (2013). Multiple interaction partners for Cockayne syndrome proteins: implications for genome and transcriptome maintenance. Mech. Ageing Dev. 134, 212-224. doi: 10.1016/j.mad.2013.03.009
2. Alisch, R. S., Wang, T., Chopra, P., Visootsak, J., Conneely, K. N., and Warren, S. T. (2013). Genome-wide analysis validates aberrant methylation in fragile X syndrome is specific to the FMR1 locus. BMC Med. Genet. 14:18. doi: 10.1186/1471-2350-14-18
3. Allen, E. G., Sullivan, A. K., Marcus, M., Small, C., Dominguez, C., Epstein, M. P.,et al. (2007). Examination of reproductive aging milestones among women who carry the FMR1 premutation. Hum. Reprod. 22, 2142-2152. doi: 10.1093/humrep/dem148
4. Ashley-Koch, A. E., Robinson, H., Glicksman, A. E., Nolin, S. L., Schwartz, C. E., Brown, W. T.,et al. (1998). Examination of factors associated with instability of the FMR1 CGG repeat. Am. J. Hum. Genet. 63, 776-785. doi: 10.1086/302018
5. Barasoain, M., Barrenetxea, G., Huerta, I., Telez, M., Carrillo, A., Perez, C.,et al. (2013). Study of FMR1 gene association with ovarian dysfunction in a sample from the Basque Country. Gene 521, 145-149. doi: 10.1016/j.gene.2013.03.032
6. Bear, M. F., Huber, K. M., and Warren, S. T. (2004). The mGluR theory of fragile X mental retardation. Trends Neurosci. 27, 370-377. doi: 10.1016/j.tins.2004.04.009
7. Beckedorff, F. C., Ayupe, A. C., Crocci-Souza, R., Amaral, M. S., Nakaya, H. I., Soltys, D. T.,et al. (2013). The intronic long noncoding RNA ANRASSF1 recruits PRC2 to the RASSF1A promoter, reducing the expression of RASSF1A and increasing cell proliferation. PLoS Genet. 9:e1003705. doi: 10.1371/journal.pgen.1003705
8. Beilina, A., Tassone, F., Schwartz, P. H., Sahota, P., and Hagerman, P. J. (2004). Redistribution of transcription start sites within the FMR1 promoter region with expansion of the downstream CGG-repeat element. Hum. Mol. Genet. 13, 543-549. doi: 10.1093/hmg/ddh053
9. Bennett, C. E., Conway, G. S., Macpherson, J. N., Jacobs, P. A., and Murray, A. (2010). Intermediate sized CGG repeats are not a common cause of idiopathic premature ovarian failure. Hum. Reprod. 25, 1335-1338. doi: 10.1093/humrep/deq058
10. Berry-Kravis, E. (2002). Epilepsy in fragile X syndrome. Dev. Med. Child Neurol. 44, 724-728. doi: 10.1111/j.1469-8749.2002.tb00277.x
11. Berry-Kravis, E., Potanos, K., Weinberg, D., Zhou, L., and Goetz, C. G. (2005). Fragile X-associated tremor/ataxia syndrome in sisters related to X-inactivation. Ann. Neurol. 57, 144-147. doi: 10.1002/ana.20360
12. Biacsi, R., Kumari, D., and Usdin, K. (2008). SIRT1 inhibition alleviates gene silencing in Fragile X mental retardation syndrome. PLoS Genet. 4:e1000017. doi: 10.1371/journal.pgen.1000017
13. Bierhoff, H., Dammert, M. A., Brocks, D., Dambacher, S., Schotta, G., and Grummt, I. (2014). Quiescence-induced LncRNAs trigger H4K20 trimethylation and transcriptional silencing. Mol. Cell 54, 675-682. doi: 10.1016/j.molcel.2014.03.032
14. Bodega, B., Bione, S., Dalpra, L., Toniolo, D., Ornaghi, F., Vegetti, W.,et al. (2006). Influence of intermediate and uninterrupted FMR1 CGG expansions in premature ovarian failure manifestation. Hum. Reprod. 21, 952-957. doi: 10.1016/j.molcel.2014.03.032
15. Bontekoe, C. J., De Graaff, E., Nieuwenhuizen, I. M., Willemsen, R., and Oostra, B. A. (1997). FMR1 premutation allele (CGG)81 is stable in mice. Eur. J. Hum. Genet. 5, 293-298. doi: 10.1093/humrep/dei432
16. Braun, K., and Segal, M. (2000). FMRP involvement in formation of synapses among cultured hippocampal neurons. Cereb. Cortex 10, 1045-1052. doi: 10.1093/cercor/10.10.1045
17. Bretherick, K. L., Fluker, M. R., and Robinson, W. P. (2005). FMR1 repeat sizes in the gray zone and high end of the normal range are associated with premature ovarian failure. Hum. Genet. 117, 376-382. doi: 10.1007/s00439-005-1326-8
18. Brouwer, J. R., Huizer, K., Severijnen, L. A., Hukema, R. K., Berman, R. F., Oostra, B. A.,et al. (2008). CGG-repeat length and neuropathological and molecular correlates in a mouse model for fragile X-associated tremor/ataxia syndrome. J. Neurochem. 107, 1671-1682. doi: 10.1111/j.1471-4159.2008.05747.x
19. Bulut-Karslioglu, A., Perrera, V., Scaranaro, M., De La Rosa-Velazquez, I. A., Van De Nobelen, S., Shukeir, N.,et al. (2012). A transcription factor-based mechanism for mouse heterochromatin formation. Nat. Struct. Mol. Biol. 19, 1023-1030. doi: 10.1038/nsmb.2382
20. Castellano-Pozo, M., Santos-Pereira, J. M., Rondon, A. G., Barroso, S., Andujar, E., Perez-Alegre, M.,et al. (2013). R loops are linked to histone H3 S10 phosphorylation and chromatin condensation. Mol. Cell 52, 583-590. doi: 10.1016/j.molcel.2013.10.006
21. Chabosseau, P., Buhagiar-Labarchede, G., Onclercq-Delic, R., Lambert, S., Debatisse, M., Brison, O.,et al. (2011). Pyrimidine pool imbalance induced by BLM helicase deficiency contributes to genetic instability in Bloom syndrome. Nat. Commun. 2, 368. doi: 10.1038/ncomms1363
22. Chen, X., Mariappan, S. V., Catasti, P., Ratliff, R., Moyzis, R. K., Laayoun, A.,et al. (1995). Hairpins are formed by the single DNA strands of the fragile X triplet repeats: structure and biological implications. Proc. Natl. Acad. Sci. U.S.A. 92, 5199-5203. doi: 10.1073/pnas.92.11.5199
23. Chiurazzi, P., Pomponi, M. G., Pietrobono, R., Bakker, C. E., Neri, G., and Oostra, B. A. (1999). Synergistic effect of histone hyperacetylation and DNA demethylation in the reactivation of the FMR1 gene. Hum. Mol. Genet. 8, 2317-2323. doi: 10.1093/hmg/8.12.2317
24. Chiurazzi, P., Pomponi, M. G., Willemsen, R., Oostra, B. A., and Neri, G. (1998). In vitro reactivation of the FMR1 gene involved in fragile X syndrome. Hum. Mol. Genet. 7, 109-113. doi: 10.1093/hmg/7.1.109
25. Chonchaiya, W., Au, J., Schneider, A., Hessl, D., Harris, S. W., Laird, M.,et al. (2012). Increased prevalence of seizures in boys who were probands with the FMR1 premutation and co-morbid autism spectrum disorder. Hum. Genet. 131, 581-589. doi: 10.1007/s00439-011-1106-6
26. Clifford, S., Dissanayake, C., Bui, Q. M., Huggins, R., Taylor, A. K., and Loesch, D. Z. (2007). Autism spectrum phenotype in males and females with fragile X full mutation and premutation. J. Autism Dev. Disord. 37, 738-747. doi: 10.1007/s10803-006-0205-z
27. Coffee, B., Zhang, F., Warren, S. T., and Reines, D. (1999). Acetylated histones are associated with FMR1 in normal but not fragile X-syndrome cells. Nat. Genet. 22, 98-101. doi: 10.1038/8807
28. Coffey, S. M., Cook, K., Tartaglia, N., Tassone, F., Nguyen, D. V., Pan, R.,et al. (2008). Expanded clinical phenotype of women with the FMR1 premutation. Am. J. Med. Genet. A 146A, 1009-1016. doi: 10.1002/ajmg.a.32060
29. Cohen, I. L., Nolin, S. L., Sudhalter, V., Ding, X. H., Dobkin, C. S., and Brown, W. T. (1996). Mosaicism for the FMR1 gene influences adaptive skills development in fragile X-affected males. Am. J. Med. Genet. 64, 365-369. doi: 10.1002/(SICI)1096-8628(19960809)64:2<365::AID-AJMG26>3.0.CO;2-C
30. Colak, D., Zaninovic, N., Cohen, M. S., Rosenwaks, Z., Yang, W. Y., Gerhardt, J.,et al. (2014). Promoter-bound trinucleotide repeat mRNA drives epigenetic silencing in fragile X syndrome. Science 343, 1002-1005. doi: 10.1126/science.1245831
31. Comery, T. A., Harris, J. B., Willems, P. J., Oostra, B. A., Irwin, S. A., Weiler, I. J.,et al. (1997). Abnormal dendritic spines in fragile X knockout mice: maturation and pruning deficits. Proc. Natl. Acad. Sci. U.S.A. 94, 5401-5404. doi: 10.1073/pnas.94.10.5401
32. De Boulle, K., Verkerk, A. J., Reyniers, E., Vits, L., Hendrickx, J., Van Roy, B.,et al. (1993). A point mutation in the FMR-1 gene associated with fragile X mental retardation. Nat. Genet. 3, 31-35. doi: 10.1038/ng0193-31
33. de Graaff, E., De Vries, B. B., Willemsen, R., Van Hemel, J. O., Mohkamsing, S., Oostra, B. A.,et al. (1996). The fragile X phenotype in a mosaic male with a deletion showing expression of the FMR1 protein in 28% of the cells. Am. J. Med. Genet. 64, 302-308. doi: 10.1002/(SICI)1096-8628(19960809)64:2<302::AID-AJMG14>3.0.CO;2-J
34. Deutsch, S. I., Rosse, R. B., Mastropaolo, J., Long, K. D., and Gaskins, B. L. (2008). Epigenetic therapeutic strategies for the treatment of neuropsychiatric disorders: ready for prime time? Clin. Neuropharmacol. 31, 104-119. doi: 10.1097/WNF.0b013e318067e255
35. de Vries, B. B., Jansen, C. C., Duits, A. A., Verheij, C., Willemsen, R., Van Hemel, J. O.,et al. (1996). Variable FMR1 gene methylation of large expansions leads to variable phenotype in three males from one fragile X family. J. Med. Genet. 33, 1007-1010. doi: 10.1136/jmg.33.12.1007
36. Devys, D., Biancalana, V., Rousseau, F., Boue, J., Mandel, J. L., and Oberle, I. (1992). Analysis of full fragile X mutations in fetal tissues and monozygotic twins indicate that abnormal methylation and somatic heterogeneity are established early in development. Am. J. Med. Genet. 43, 208-216. doi: 10.1002/ajmg.1320430134
37. Dobkin, C., Radu, G., Ding, X. H., Brown, W. T., and Nolin, S. L. (2009). Fragile X prenatal analyses show full mutation females at high risk for mosaic Turner syndrome: fragile X leads to chromosome loss. Am. J. Med. Genet. 149A, 2152-2157. doi: 10.1002/ajmg.a.33011
38. Dobkin, C. S., Nolin, S. L., Cohen, I., Sudhalter, V., Bialer, M. G., Ding, X. H.,et al. (1996). Tissue differences in fragile X mosaics: mosaicism in blood cells may differ greatly from skin. Am. J. Med. Genet. 64, 296-301. doi: 10.1002/(SICI)1096-8628(19960809)64:2<296::AID-AJMG13>3.0.CO;2-A
39. Dolen, G., and Bear, M. F. (2008). Role for metabotropic glutamate receptor 5 (mGluR5) in the pathogenesis of fragile X syndrome. J. Physiol. 586, 1503-1508. doi: 10.1113/jphysiol.2008.150722
40. Dong, K. B., Maksakova, I. A., Mohn, F., Leung, D., Appanah, R., Lee, S.,et al. (2008). DNA methylation in ES cells requires the lysine methyltransferase G9a but not its catalytic activity. EMBO J. 27, 2691-2701. doi: 10.1038/emboj.2008.193
41. Du, J., Campau, E., Soragni, E., Ku, S., Puckett, J. W., Dervan, P. B.,et al. (2012). Role of mismatch repair enzymes in GAA.TTC triplet-repeat expansion in Friedreich ataxia induced pluripotent stem cells. J. Biol. Chem. 287, 29861-29872. doi: 10.1074/jbc.M112.391961
42. Dunn, K., and Griffith, J. D. (1980). The presence of RNA in a double helix inhibits its interaction with histone protein. Nucleic Acids Res. 11, 555-566. doi: 10.1093/nar/8.3.555
43. Eichler, E. E., Holden, J. J., Popovich, B. W., Reiss, A. L., Snow, K., Thibodeau, S. N.,et al. (1994). Length of uninterrupted CGG repeats determines instability in the FMR1 gene. Nat. Genet. 8, 88-94. doi: 10.1038/ng0994-88
44. Eiges, R., Urbach, A., Malcov, M., Frumkin, T., Schwartz, T., Amit, A.,et al. (2007). Developmental study of fragile X syndrome using human embryonic stem cells derived from preimplantation genetically diagnosed embryos. Cell Stem Cell 1, 568-577. doi: 10.1016/j.stem.2007.09.001
45. Ennis, S., Ward, D., and Murray, A. (2006). Nonlinear association between CGG repeat number and age of menopause in FMR1 premutation carriers. Eur. J. Hum. Genet. 14, 253-255. doi: 10.1038/sj.ejhg.5201510
46. Entezam, A., Biacsi, R., Orrison, B., Saha, T., Hoffman, G. E., Grabczyk, E.,et al. (2007). Regional FMRP deficits and large repeat expansions into the full mutation range in a new Fragile X premutation mouse model. Gene 395, 125-134. doi: 10.1016/j.gene.2007.02.026
47. Entezam, A., Lokanga, A. R., Le, W., Hoffman, G., and Usdin, K. (2010). Potassium bromate, a potent DNA oxidizing agent, exacerbates germline repeat expansion in a fragile X premutation mouse model. Hum. Mutat. 31, 611-616. doi: 10.1002/humu.21237
48. Entezam, A., and Usdin, K. (2008). ATR protects the genome against CGG.CCG-repeat expansion in Fragile X premutation mice. Nucleic Acids Res. 36, 1050-1056. doi: 10.1093/nar/gkm1136
49. Entezam, A., and Usdin, K. (2009). ATM and ATR protect the genome against two different types of tandem repeat instability in Fragile X premutation mice. Nucleic Acids Res. 37, 6371-6377. doi: 10.1093/nar/gkp666
50. Epsztejn-Litman, S., Feldman, N., Abu-Remaileh, M., Shufaro, Y., Gerson, A., Ueda, J.,et al. (2008). De novo DNA methylation promoted by G9a prevents reprogramming of embryonically silenced genes. Nat. Struct. Mol. Biol. 15, 1176-1183. doi: 10.1038/nsmb.1476
51. Fan, H., Booker, J. K., Mccandless, S. E., Shashi, V., Fleming, A., and Farber, R. A. (2005). Mosaicism for an FMR1 gene deletion in a fragile X female. Am. J. Med. Genet. A 136, 214-217. doi: 10.1002/ajmg.a.30807
52. Farzin, F., Perry, H., Hessl, D., Loesch, D., Cohen, J., Bacalman, S.,et al. (2006). Autism spectrum disorders and attention-deficit/hyperactivity disorder in boys with the fragile X premutation. J. Dev. Behav. Pediatr. 27, S137-S144. doi: 10.1097/00004703-200604002-00012
53. Feldman, N., Gerson, A., Fang, J., Li, E., Zhang, Y., Shinkai, Y.,et al. (2006). G9a-mediated irreversible epigenetic inactivation of Oct-3/4 during early embryogenesis. Nat. Cell Biol. 8, 188-194. doi: 10.1038/ncb1353
54. Ferreira, S. I., Pires, L. M., Ferrao, J., Sa, J., Serra, A., and Carreira, I. M. (2013). Mosaicism for FMR1 gene full mutation and intermediate allele in a female foetus: a postzygotic retraction event. Gene 527, 421-425. doi: 10.1016/j.gene.2013.05.079
55. Fleming, K., Riser, D. K., Kumari, D., and Usdin, K. (2003). Instability of the fragile X syndrome repeat in mice: the effect of age, diet and mutations in genes that affect DNA replication, recombination and repair proficiency. Cytogenet. Genome Res. 100, 140-146. doi: 10.1159/000072848
56. Foiry, L., Dong, L., Savouret, C., Hubert, L., Te Riele, H., Junien, C.,et al. (2006). Msh3 is a limiting factor in the formation of intergenerational CTG expansions in DM1 transgenic mice. Hum. Genet. 119, 520-526. doi: 10.1007/s00439-006-0164-7
57. Fojtik, P., and Vorlickova, M. (2001). The fragile X chromosome (GCC) repeat folds into a DNA tetraplex at neutral pH. Nucleic Acids Res. 29, 4684-4690. doi: 10.1093/nar/29.22.4684
58. Fortune, M. T., Vassilopoulos, C., Coolbaugh, M. I., Siciliano, M. J., and Monckton, D. G. (2000). Dramatic, expansion-biased, age-dependent, tissue-specific somatic mosaicism in a transgenic mouse model of triplet repeat instability. Hum. Mol. Genet. 9, 439-445. doi: 10.1093/hmg/9.3.439
59. Fry, M., and Loeb, L. A. (1994). The fragile X syndrome d(CGG)n nucleotide repeats form a stable tetrahelical structure. Proc. Natl. Acad. Sci. U.S.A. 91, 4950-4954. doi: 10.1073/pnas.91.11.4950
60. Fry, M., and Usdin, K. (2006). Human Nucleotide Expansion Disorders. Heidelberg: Springer. doi: 10.1007/3-540-33336-3
61. Fu, Y. H., Kuhl, D. P., Pizzuti, A., Pieretti, M., Sutcliffe, J. S., Richards, S.,et al. (1991). Variation of the CGG repeat at the fragile X site results in genetic instability: resolution of the Sherman paradox. Cell 67, 1047-1058. doi: 10.1016/0092-8674(91)90283-5
62. Gan, W., Guan, Z., Liu, J., Gui, T., Shen, K., Manley, J. L.,et al. (2011). R-loop-mediated genomic instability is caused by impairment of replication fork progression. Genes Dev. 25, 2041-2056. doi: 10.1101/gad.17010011
63. Garcia Arocena, D., De Diego, Y., Oostra, B. A., Willemsen, R., and Mirta Rodriguez, M. (2000). A fragile X case with an amplification/deletion mosaic pattern. Hum. Genet. 106, 366-369. doi: 10.1007/s004390051052
64. Gasteiger, M., Grasbon-Frodl, E., Neitzel, B., Kooy, F., and Holinski-Feder, E. (2003). FMR1 gene deletion/reversion: a pitfall of fragile X carrier testing. Genet. Test. 7, 303-308. doi: 10.1089/109065703322783653
65. Gerhardt, J., Tomishima, M. J., Zaninovic, N., Colak, D., Yan, Z., Zhan, Q.,et al. (2014). The DNA replication program is altered at the FMR1 locus in fragile X embryonic stem cells. Mol. Cell 53, 19-31. doi: 10.1016/j.molcel.2013.10.029
66. Govaerts, L. C., Smit, A. E., Saris, J. J., Vanderwerf, F., Willemsen, R., Bakker, C. E.,et al. (2007). Exceptional good cognitive and phenotypic profile in a male carrying a mosaic mutation in the FMR1 gene. Clin. Genet. 72, 138-144. doi: 10.1111/j.1399-0004.2007.00829.x
67. Grasso, M., Faravelli, F., Lo Nigro, C., Chiurazzi, P., Sperandeo, M. P., Argusti, A.,et al. (1999). Mosaicism for the full mutation and a microdeletion involving the CGG repeat and flanking sequences in the FMR1 gene in eight fragile X patients. Am. J. Med. Genet. 85, 311-316. doi: 10.1002/(SICI)1096-8628(19990730)85:3<311::AID-AJMG24>3.0.CO;2-A
68. Grigsby, J., Brega, A. G., Jacquemont, S., Loesch, D. Z., Leehey, M. A., Goodrich, G. K.,et al. (2006). Impairment in the cognitive functioning of men with fragile X-associated tremor/ataxia syndrome (FXTAS). J. Neurol. Sci. 248, 227-233. doi: 10.1016/j.jns.2006.05.016
69. Grigsby, J., Brega, A. G., Leehey, M. A., Goodrich, G. K., Jacquemont, S., Loesch, D. Z.,et al. (2007). Impairment of executive cognitive functioning in males with fragile X-associated tremor/ataxia syndrome. Mov. Disord. 22, 645-650. doi: 10.1002/mds.21359
70. Groh, M., Lufino, M. M., Wade-Martins, R., and Gromak, N. (2014). R-loops associated with triplet repeat expansions promote gene silencing in Friedreich ataxia and fragile X syndrome. PLoS Genet. 10:e1004318. doi: 10.1371/journal.pgen.1004318
71. Gu, Y., Lugenbeel, K. A., Vockley, J. G., Grody, W. W., and Nelson, D. L. (1994). A de novo deletion in FMR1 in a patient with developmental delay. Hum. Mol. Genet. 3, 1705-1706. doi: 10.1093/hmg/3.9.1705
72. Haeusler, A. R., Donnelly, C. J., Periz, G., Simko, E. A., Shaw, P. G., Kim, M. S.,et al. (2014). C9orf72 nucleotide repeat structures initiate molecular cascades of disease. Nature 507, 195-200. doi: 10.1038/nature13124
73. Hagerman, P. (2013). Fragile X-associated tremor/ataxia syndrome (FXTAS): pathology and mechanisms. Acta Neuropathol. 126, 1-19. doi: 10.1007/s00401-013-1138-1
74. Hagerman, R. J., and Hagerman, P. J. (2008). Testing for fragile X gene mutations throughout the life span. JAMA 300, 2419-2421. doi: 10.1001/jama.2008.684
75. Hagerman, R. J., Hull, C. E., Safanda, J. F., Carpenter, I., Staley, L. W., O'Connor, R. A.,et al. (1994). High functioning fragile X males: demonstration of an unmethylated fully expanded FMR-1 mutation associated with protein expression. Am. J. Med. Genet. 51, 298-308. doi: 10.1002/ajmg.1320510404
76. Hagerman, R. J., Staley, L. W., O'Conner, R., Lugenbeel, K., Nelson, D., Mclean, S. D.,et al. (1996). Learning-disabled males with a fragile X CGG expansion in the upper premutation size range. Pediatrics 97, 122-126.
77. Hahnen, E., Eyupoglu, I. Y., Brichta, L., Haastert, K., Trankle, C., Siebzehnrubl, F. A.,et al. (2006). In vitro and ex vivo evaluation of second-generation histone deacetylase inhibitors for the treatment of spinal muscular atrophy. J. Neurochem. 98, 193-202. doi: 10.1111/j.1471-4159.2006.03868.x
78. Halabi, A., Ditch, S., Wang, J., and Grabczyk, E. (2012). DNA mismatch repair complex MutSß promotes GAA.TTC repeat expansion in human cells. J. Biol. Chem. 287, 29958-29967. doi: 10.1074/jbc.M112.356758
79. Hall, D., Tassone, F., Klepitskaya, O., and Leehey, M. (2012). Fragile X-associated tremor ataxia syndrome in FMR1 gray zone allele carriers. Mov. Disord. 27, 296-300. doi: 10.1002/mds.24021
80. Hall, D. A., Berry-Kravis, E., Zhang, W., Tassone, F., Spector, E., Zerbe, G.,et al. (2011). FMR1 gray-zone alleles: association with Parkinson's disease in women? Mov. Disord. 26, 1900-1906. doi: 10.1002/mds.23755
81. Handa, V., Saha, T., and Usdin, K. (2003). The fragile X syndrome repeats form RNA hairpins that do not activate the interferon-inducible protein kinase, PKR, but are cut by Dicer. Nucleic Acids Res. 31, 6243-6248. doi: 10.1093/nar/gkg818
82. Hansen, R. S., Canfield, T. K., Lamb, M. M., Gartler, S. M., and Laird, C. D. (1993). Association of fragile X syndrome with delayed replication of the FMR1 gene. Cell 73, 1403-1409. doi: 10.1016/0092-8674(93)90365-W
83. Heitz, D., Devys, D., Imbert, G., Kretz, C., and Mandel, J. L. (1992). Inheritance of the fragile X syndrome: size of the fragile X premutation is a major determinant of the transition to full mutation. J. Med. Genet. 29, 794-801. doi: 10.1136/jmg.29.11.794
84. Hessl, D., Rivera, S., Koldewyn, K., Cordeiro, L., Adams, J., Tassone, F.,et al. (2007). Amygdala dysfunction in men with the fragile X premutation. Brain 130, 404-416. doi: 10.1093/brain/awl338
85. Hook, E. B., and Warburton, D. (1983). The distribution of chromosomal genotypes associated with Turner's syndrome: livebirth prevalence rates and evidence for diminished fetal mortality and severity in genotypes associated with structural X abnormalities or mosaicism. Hum. Genet. 64, 24-27. doi: 10.1007/BF00289473
86. Howard-Peebles, P. N., and Stoddard, G. R. (1979). X-linked mental retardation with macro-orchidism and marker X chromosomes. Hum. Mutat. 50, 247-251.
87. Huang, C. C., Chiribau, C. B., Majumder, M., Chiang, C. M., Wek, R. C., Kelm, R. J.,et al. (2009). A bifunctional intronic element regulates the expression of the arginine/lysine transporter Cat-1 via mechanisms involving the purine-rich element binding protein A (Pur alpha). J. Biol. Chem. 284, 32312-32320. doi: 10.1074/jbc.M109.024471
88. Huang, W., Luo, S., Ou, J., Zhu, F., Xia, Y., Xue, J.,et al. (2014). Correlation between FMR1 expression and clinical phenotype in discordant dichorionic-diamniotic monozygotic twin sisters with the fragile X mutation. J. Med. Genet. 51, 159-164. doi: 10.1136/jmedgenet-2013-101978
89. Irwin, S. A., Galvez, R., and Greenough, W. T. (2000). Dendritic spine structural anomalies in fragile-X mental retardation syndrome. Cereb. Cortex 10, 1038-1044. doi: 10.1093/cercor/10.10.1038
90. Ishiguro, H., Yamada, K., Sawada, H., Nishii, K., Ichino, N., Sawada, M.,et al. (2001). Age-dependent and tissue-specific CAG repeat instability occurs in mouse knock-in for a mutant Huntington's disease gene. J. Neurosci. Res. 65, 289-297. doi: 10.1002/jnr.1153
91. Ishizuka, B., Okamoto, N., Hamada, N., Sugishita, Y., Saito, J., Takahashi, N.,et al. (2011). Number of CGG repeats in the FMR1 gene of Japanese patients with primary ovarian insufficiency. Fertil. Steril. 96, 1170-1174. doi: 10.1016/j.fertnstert.2011.08.028
92. Iwahashi, C. K., Yasui, D. H., An, H. J., Greco, C. M., Tassone, F., Nannen, K.,et al. (2006). Protein composition of the intranuclear inclusions of FXTAS. Brain 129, 256-271. doi: 10.1093/brain/awh650
93. Jacquemont, S. (2005). Screening for FXTAS. Eur. J. Hum. Genet. 13, 2-3. doi: 10.1038/sj.ejhg.5201318
94. Jacquemont, S., Hagerman, R. J., Leehey, M. A., Hall, D. A., Levine, R. A., Brunberg, J. A.,et al. (2004). Penetrance of the fragile X-associated tremor/ataxia syndrome in a premutation carrier population. JAMA 291, 460-469. doi: 10.1001/jama.291.4.460
95. James, S. J., Cross, D. R., and Miller, B. J. (1992). Alterations in nucleotide pools in rats fed diets deficient in choline, methionine and/or folic acid. Carcinogenesis 13, 2471-2474. doi: 10.1093/carcin/13.12.2471
96. Jarem, D. A., Huckaby, L. V., and Delaney, S. (2010). AGG interruptions in (CGG)n DNA repeat tracts modulate the structure and thermodynamics of non-B conformations in vitro. Biochemistry 49, 6826-6837. doi: 10.1021/bi1007782
97. Jin, P., Duan, R., Qurashi, A., Qin, Y., Tian, D., Rosser, T. C.,et al. (2007). Pur a binds to rCGG repeats and modulates repeat-mediated neurodegeneration in a Drosophila model of fragile X tremor/ataxia syndrome. Neuron 55, 556-564. doi: 10.1016/j.neuron.2007.07.020
98. Kanhere, A., Viiri, K., Araujo, C. C., Rasaiyaah, J., Bouwman, R. D., Whyte, W. A.,et al. (2010). Short RNAs are transcribed from repressed polycomb target genes and interact with polycomb repressive complex-2. Mol. Cell 38, 675-688. doi: 10.1016/j.molcel.2010.03.019
99. Karimov, C. B., Moragianni, V. A., Cronister, A., Srouji, S., Petrozza, J., Racowsky, C.,et al. (2011). Increased frequency of occult fragile X-associated primary ovarian insufficiency in infertile women with evidence of impaired ovarian function. Hum. Reprod. 26, 2077-2083. doi: 10.1093/humrep/der168
100. Kenneson, A., Zhang, F., Hagedorn, C. H., and Warren, S. T. (2001). Reduced FMRP and increased FMR1 transcription is proportionally associated with CGG repeat number in intermediate-length and premutation carriers. Hum. Mol. Genet. 10, 1449-1454. doi: 10.1093/hmg/10.14.1449
101. Kim, D. H., Villeneuve, L. M., Morris, K. V., and Rossi, J. J. (2006). Argonaute-1 directs siRNA-mediated transcriptional gene silencing in human cells. Nat. Struct. Mol. Biol. 13, 793-797. doi: 10.1038/nsmb1142
102. Kim, S. Y., Burris, J., Bassal, F., Koldewyn, K., Chattarji, S., Tassone, F.,et al. (2014). Fear-specific amygdala function in children and adolescents on the fragile X spectrum: a dosage response of the FMR1 gene. Cereb. Cortex 24, 600-613. doi: 10.1093/cercor/bhs341
103. Kovtun, I. V., Liu, Y., Bjoras, M., Klungland, A., Wilson, S. H., and Mcmurray, C. T. (2007). OGG1 initiates age-dependent CAG trinucleotide expansion in somatic cells. Nature 447, 447-452. doi: 10.1038/nature05778
104. Kovtun, I. V., and McMurray, C. T. (2001). Trinucleotide expansion in haploid germ cells by gap repair. Nat. Genet. 27, 407-411. doi: 10.1038/86906
105. Kumari, D., and Usdin, K. (2010). The distribution of repressive histone modifications on silenced FMR1 alleles provides clues to the mechanism of gene silencing in fragile X syndrome. Hum. Mol. Genet. 19, 4634-4642. doi: 10.1093/hmg/ddq394
106. Kunst, C. B., Leeflang, E. P., Iber, J. C., Arnheim, N., and Warren, S. T. (1997). The effect of FMR1 CGG repeat interruptions on mutation frequency as measured by sperm typing. J. Med. Genet. 34, 627-631. doi: 10.1136/jmg.34.8.627
107. Ladd, P. D., Smith, L. E., Rabaia, N. A., Moore, J. M., Georges, S. A., Hansen, R. S.,et al. (2007). An antisense transcript spanning the CGG repeat region of FMR1 is upregulated in premutation carriers but silenced in full mutation individuals. J. Neurosci. Res. 16, 3174-3187.
108. Lang, W. H., Coats, J. E., Majka, J., Hura, G. L., Lin, Y., Rasnik, I.,et al. (2011). Conformational trapping of mismatch recognition complex MSH2/MSH3 on repair-resistant DNA loops. Proc. Natl. Acad. Sci. U.S.A. 108, E837-E844. doi: 10.1073/pnas.1105461108
109. Lanni, S., Goracci, M., Borrelli, L., Mancano, G., Chiurazzi, P., Moscato, U.,et al. (2013). Role of CTCF protein in regulating FMR1 locus transcription. PLoS Genet. 9:e1003601. doi: 10.1371/journal.pgen.1003601
110. Lavedan, C., Grabczyk, E., Usdin, K., and Nussbaum, R. L. (1998). Long uninterrupted CGG repeats within the first exon of the human FMR1 gene are not intrinsically unstable in transgenic mice. Genomics 50, 229-240. doi: 10.1006/geno.1998.5299
111. Leehey, M. A., Berry-Kravis, E., Goetz, C. G., Zhang, L., Hall, D. A., Li, L.,et al. (2008). FMR1 CGG repeat length predicts motor dysfunction in premutation carriers. Neurology 70, 1397-1402. doi: 10.1212/01.wnl.0000281692.98200.f5
112. Lia, A. S., Seznec, H., Hofmann-Radvanyi, H., Radvanyi, F., Duros, C., Saquet, C.,et al. (1998). Somatic instability of the CTG repeat in mice transgenic for the myotonic dystrophy region is age dependent but not correlated to the relative intertissue transcription levels and proliferative capacities. Hum. Mol. Genet. 7, 1285-1291. doi: 10.1093/hmg/7.8.1285
113. Liu, Y., Winarni, T. I., Zhang, L., Tassone, F., and Hagerman, R. J. (2013). Fragile X-associated tremor/ataxia syndrome (FXTAS) in grey zone carriers. Clin. Genet. 84, 74-77. doi: 10.1111/cge.12026
114. Loesch, D. Z., Bui, Q. M., Huggins, R. M., Mitchell, R. J., Hagerman, R. J., and Tassone, F. (2007). Transcript levels of the intermediate size or grey zone fragile X mental retardation 1 alleles are raised, and correlate with the number of CGG repeats. J. Med. Genet. 44, 200-204. doi: 10.1136/jmg.2006.043950
115. Loesch, D. Z., Godler, D. E., Khaniani, M., Gould, E., Gehling, F., Dissanayake, C.,et al. (2009). Linking the FMR1 alleles with small CGG expansions with neurodevelopmental disorders: preliminary data suggest an involvement of epigenetic mechanisms. Am. J. Med. Genet. A 149A, 2306-2310. doi: 10.1002/ajmg.a.32990
116. Loesch, D. Z., Huggins, R. M., and Hagerman, R. J. (2004). Phenotypic variation and FMRP levels in fragile X. Ment. Retard. Dev. Disabil. Res. Rev. 10, 31-41. doi: 10.1002/mrdd.20006
117. Loesch, D. Z., Petrovic, V., Francis, D. I., Oertel, R., and Slater, H. (1997). "Reduction" of CGG trinucleotide expansion from mother to offspring in seven fragile-X families. Clin. Genet. 51, 1-6. doi: 10.1111/j.1399-0004.1997.tb02405.x
118. Loesch, D. Z., Sherwell, S., Kinsella, G., Tassone, F., Taylor, A., Amor, D.,et al. (2012). Fragile X-associated tremor/ataxia phenotype in a male carrier of unmethylated full mutation in the FMR1 gene. Clin. Genet. 82, 88-92. doi: 10.1111/j.1399-0004.2011.01675.x
119. Lokanga, A. R., Zhao, X.-N., and Usdin, K. (2014a). X inactivation plays a major role in the gender bias in somatic expansion in a mouse model of the Fragile X-related disorders: implications for the mechanism of repeat expansion. Hum. Mol. Genet. doi: 10.1093/hmg/ddu213 [Epub ahead of print].
120. Lokanga, R. A., Zhao, X.-N., and Usdin, K. (2014b). The mismatch repair protein, MSH2, is rate-limiting for repeat expansion in a fragile X premutation mouse model. Hum. Mutat. 35, 129-136. doi: 10.1002/humu.22464
121. Lokanga, R. A., Entezam, A., Kumari, D., Yudkin, D., Qin, M., Smith, C. B.,et al. (2013). Somatic expansion in mouse and human carriers of fragile X premutation alleles. Hum. Mutat. 34, 157-166. doi: 10.1002/humu.22177
122. Loomis, E. W., Sanz, L. A., Chedin, F., and Hagerman, P. J. (2014). Transcription-associated R-loop formation across the human FMR1 CGG-repeat region. PLoS Genet. 10:e1004294. doi: 10.1371/journal.pgen.1004294
123. Lugenbeel, K. A., Peier, A. M., Carson, N. L., Chudley, A. E., and Nelson, D. L. (1995). Intragenic loss of function mutations demonstrate the primary role of FMR1 in fragile X syndrome. Nat. Genet. 10, 483-485. doi: 10.1038/ng0895-483
124. Lukusa, T., and Fryns, J. P. (2008). Human chromosome fragility. Biochim. Biophys. Acta 1779, 3-16. doi: 10.1016/j.bbagrm.2007.10.005
125. Maddalena, A., Yadvish, K. N., Spence, W. C., and Howard-Peebles, P. N. (1996). A fragile X mosaic male with a cryptic full mutation detected in epithelium but not in blood. Am. J. Med. Genet. 64, 309-312. doi: 10.1002/(SICI)1096-8628(19960809)64:2<309::AID-AJMG15>3.0.CO;2-J
126. Malter, H. E., Iber, J. C., Willemsen, R., De Graaff, E., Tarleton, J. C., Leisti, J.,et al. (1997). Characterization of the full fragile X syndrome mutation in fetal gametes. Nat. Genet. 15, 165-169. doi: 10.1038/ng0297-165
127. Malzac, P., Biancalana, V., Voelckel, M. A., Moncla, A., Pellissier, M. C., Boccaccio, I.,et al. (1996). Unexpected inheritance of the (CGG)n trinucleotide expansion in a fragile X syndrome family. Eur. J. Hum. Genet. 4, 8-12.
128. Manley, K., Shirley, T. L., Flaherty, L., and Messer, A. (1999). Msh2 deficiency prevents in vivo somatic instability of the CAG repeat in Huntington disease transgenic mice. Nat. Genet. 23, 471-473. doi: 10.1038/70598
129. McConkie-Rosell, A., Lachiewicz, A. M., Spiridigliozzi, G. A., Tarleton, J., Schoenwald, S., Phelan, M. C.,et al. (1993). Evidence that methylation of the FMR-I locus is responsible for variable phenotypic expression of the fragile X syndrome. Am. J. Hum. Genet. 53, 800-809.
130. McLennan, Y., Polussa, J., Tassone, F., and Hagerman, R. (2011). Fragile x syndrome. Curr. Genomics 12, 216-224. doi: 10.2174/138920211795677886
131. Mendenhall, E. M., Koche, R. P., Truong, T., Zhou, V. W., Issac, B., Chi, A. S.,et al. (2010). GC-rich sequence elements recruit PRC2 in mammalian ES cells. PLoS Genet. 6:e1001244. doi: 10.1371/journal.pgen.1001244
132. Menoni, H., Hoeijmakers, J. H., and Vermeulen, W. (2012). Nucleotide excision repair-initiating proteins bind to oxidative DNA lesions in vivo. J. Cell Biol. 199, 1037-1046. doi: 10.1083/jcb.201205149
133. Mila, M., Castellvi-Bel, S., Sanchez, A., Lazaro, C., Villa, M., and Estivill, X. (1996). Mosaicism for the fragile X syndrome full mutation and deletions within the CGG repeat of the FMR1 gene. J. Med. Genet. 33, 338-340. doi: 10.1136/jmg.33.4.338
134. Mirkin, S. M. (2007). Expandable DNA repeats and human disease. Nature 447, 932-940. doi: 10.1038/nature05977
135. Mirkin, S. M., and Smirnova, E. V. (2002). Positioned to expand. Nat. Genet. 31, 5-6. doi: 10.1038/ng0502-5
136. Mitas, M., Yu, A., Dill, J., and Haworth, I. S. (1995). The trinucleotide repeat sequence d(CGG)15 forms a heat-stable hairpin containing Gsyn. Ganti base pairs. Biochemistry 34, 12803-12811. doi: 10.1021/bi00039a041
137. Mollersen, L., Rowe, A. D., Illuzzi, J. L., Hildrestrand, G. A., Gerhold, K. J., Tveteras, L.,et al. (2012). Neil1 is a genetic modifier of somatic and germline CAG trinucleotide repeat instability in R6/1 mice. Hum. Mol. Genet. 21, 4939-4947. doi: 10.1093/hmg/dds337
138. Mornet, E., Chateau, C., Taillandier, A., Simon-Bouy, B., and Serre, J. L. (1996). Recurrent and unexpected segregation of the FMR1 CGG repeat in a family with fragile X syndrome. Hum. Genet. 97, 512-515. doi: 10.1007/BF02267077
139. Moutou, C., Vincent, M. C., Biancalana, V., and Mandel, J. L. (1997). Transition from premutation to full mutation in fragile X syndrome is likely to be prezygotic. Hum. Mol. Genet. 6, 971-979. doi: 10.1093/hmg/6.7.971
140. Muftuoglu, M., De Souza-Pinto, N. C., Dogan, A., Aamann, M., Stevnsner, T., Rybanska, I.,et al. (2009). Cockayne syndrome group B protein stimulates repair of formamidopyrimidines by NEIL1 DNA glycosylase. J. Biol. Chem. 284, 9270-9279. doi: 10.1074/jbc.M807006200
141. Murray, A., Ennis, S., and Morton, N. (2000). No evidence for parent of origin influencing premature ovarian failure in fragile X premutation carriers. Am. J. Hum. Genet. 67, 253-254; author reply 256-258. doi: 10.1086/302963
142. Murray, A., Schoemaker, M. J., Bennett, C. E., Ennis, S., Macpherson, J. N., Jones, M.,et al. (2014). Population-based estimates of the prevalence of FMR1 expansion mutations in women with early menopause and primary ovarian insufficiency. Genet. Med. 16, 19-24. doi: 10.1038/gim.2013.64
143. Myrick, L. K., Nakamoto-Kinoshita, M., Lindor, N. M., Kirmani, S., Cheng, X., and Warren, S. T. (2014). Fragile X syndrome due to a missense mutation. Eur. J. Hum. Genet. doi: 10.1038/ejhg.2013.311 [Epub ahead of print].
144. Nadel, Y., Weisman-Shomer, P., and Fry, M. (1995). The fragile X syndrome single strand d(CGG)n nucleotide repeats readily fold back to form unimolecular hairpin structures. J. Biol. Chem. 270, 28970-28977. doi: 10.1074/jbc.270.48.28970
145. Nakayama, J., Rice, J. C., Strahl, B. D., Allis, C. D., and Grewal, S. I. (2001). Role of histone H3 lysine 9 methylation in epigenetic control of heterochromatin assembly. Science 292, 110-113. doi: 10.1126/science.1060118
146. Nolin, S. L., Dobkin, C., and Brown, W. T. (2003). Molecular analysis of fragile X syndrome. Curr. Protoc. Hum. Genet. Chap. 9, Unit 9.5. doi: 10.1002/0471142905.hg0905s38
147. Nolin, S. L., Glicksman, A., Ding, X., Ersalesi, N., Brown, W. T., Sherman, S. L.,et al. (2011). Fragile X analysis of 1112 prenatal samples from 1991 to 2010. Prenat. Diagn. 31, 925-931. doi: 10.1002/pd.2815
148. Nolin, S. L., Glicksman, A., Houck, G. E. Jr., Brown, W. T., and Dobkin, C. S. (1994). Mosaicism in fragile X affected males. Am. J. Med. Genet. 51, 509-512. doi: 10.1002/ajmg.1320510444
149. Nolin, S. L., Lewis, F. A. III, Ye, L. L., Houck, G. E. Jr., Glicksman, A. E., Limprasert, P.,et al. (1996). Familial transmission of the FMR1 CGG repeat. Am. J. Hum. Genet. 59, 1252-1261.
150. Nolin, S. L., Sah, S., Glicksman, A., Sherman, S. L., Allen, E., Berry-Kravis, E.,et al. (2013). Fragile X AGG analysis provides new risk predictions for 45-69 repeat alleles. Am. J. Med. Genet. A 161A, 771-778. doi: 10.1002/ajmg.a.35833
151. Nowicki, S. T., Tassone, F., Ono, M. Y., Ferranti, J., Croquette, M. F., Goodlin-Jones, B.,et al. (2007). The Prader-Willi phenotype of fragile X syndrome. J. Dev. Behav. Pediatr. 28, 133-138. doi: 10.1097/01.DBP.0000267563.18952.c9
152. Owen, B. A., Yang, Z., Lai, M., Gajek, M., Badger, J. D. III, Hayes, J. J.,et al. (2005). (CAG)n-hairpin DNA binds to Msh2-Msh3 and changes properties of mismatch recognition. Nat. Struct. Mol. Biol. 12, 663-670. doi: 10.1038/nsmb965
153. Pastore, L. M., Young, S. L., Baker, V. L., Karns, L. B., Williams, C. D., and Silverman, L. M. (2012). Elevated prevalence of 35-44 FMR1 trinucleotide repeats in women with diminished ovarian reserve. Reprod. Sci. 19, 1226-1231. doi: 10.1177/1933719112446074
154. Pastori, C., Peschansky, V. J., Barbouth, D., Mehta, A., Silva, J. P., and Wahlestedt, C. (2014). Comprehensive analysis of the transcriptional landscape of the human FMR1 gene reveals two new long noncoding RNAs differentially expressed in Fragile X syndrome and Fragile X-associated tremor/ataxia syndrome. Hum. Genet. 133, 59-67. doi: 10.1007/s00439-013-1356-6
155. Pearson, C. E., Nichol Edamura, K., and Cleary, J. D. (2005). Repeat instability: mechanisms of dynamic mutations. Nat. Rev. Genet. 6, 729-742. doi: 10.1038/nrg1689
156. Peier, A. M., and Nelson, D. L. (2002). Instability of a premutation-sized CGG repeat in FMR1 YAC transgenic mice. Genomics 80, 423-432. doi: 10.1006/geno.2002.6849
157. Pelotti, S., Bini, C., Ceccardi, S., Ferri, G., Abbondanza, A., Greggio, N. A.,et al. (2003). Sex chromosome analysis in Turner syndrome by a pentaplex PCR assay. Genet. Test. 7, 245-247. doi: 10.1089/109065703322537278
158. Petek, E., Kroisel, P. M., Schuster, M., Zierler, H., and Wagner, K. (1999). Mosaicism in a fragile X male including a de novo deletion in the FMR1 gene. Am. J. Med. Genet. 84, 229-232. doi: 10.1002/(SICI)1096-8628(19990528)84:3<229::AID-AJMG13>3.0.CO;2-T
159. Pieretti, M., Zhang, F. P., Fu, Y. H., Warren, S. T., Oostra, B. A., Caskey, C. T.,et al. (1991). Absence of expression of the FMR-1 gene in fragile X syndrome. Cell 66, 817-822. doi: 10.1016/0092-8674(91)90125-I
160. Pietrobono, R., Pomponi, M. G., Tabolacci, E., Oostra, B., Chiurazzi, P., and Neri, G. (2002). Quantitative analysis of DNA demethylation and transcriptional reactivation of the FMR1 gene in fragile X cells treated with 5-azadeoxycytidine. Nucleic Acids Res. 30, 3278-3285. doi: 10.1093/nar/gkf434
161. Pietrobono, R., Tabolacci, E., Zalfa, F., Zito, I., Terracciano, A., Moscato, U.,et al. (2005). Molecular dissection of the events leading to inactivation of the FMR1 gene. Hum. Mol. Genet. 14, 267-277. doi: 10.1093/hmg/ddi024
162. Powell, W. T., Coulson, R. L., Gonzales, M. L., Crary, F. K., Wong, S. S., Adams, S.,et al. (2013). R-loop formation at Snord116 mediates topotecan inhibition of Ube3a-antisense and allele-specific chromatin decondensation. Proc. Natl. Acad. Sci. U.S.A. 110, 13938-13943. doi: 10.1073/pnas.1305426110
163. Pretto, D. I., Hunsaker, M. R., Cunningham, C. L., Greco, C. M., Hagerman, R. J., Noctor, S. C.,et al. (2013). Intranuclear inclusions in a fragile X mosaic male. Transl. Neurodegener. 2, 10. doi: 10.1186/2047-9158-2-10
164. Pretto, D. I., Mendoza-Morales, G., Lo, J., Cao, R., Hadd, A., Latham, G. J.,et al. (2014). CGG allele size somatic mosaicism and methylation in FMR1 premutation alleles. J. Med. Genet. 51, 309-318. doi: 10.1136/jmedgenet-2013-102021
165. Prior, T. W., Papp, A. C., Snyder, P. J., Sedra, M. S., Guida, M., and Enrile, B. G. (1995). Germline mosaicism at the fragile X locus. Am. J. Med. Genet. 55, 384-386. doi: 10.1002/ajmg.1320550327
166. Renciuk, D., Zemanek, M., Kejnovska, I., and Vorlickova, M. (2009). Quadruplex-forming properties of FRAXA (CGG) repeats interrupted by (AGG) triplets. Biochimie 91, 416-422. doi: 10.1016/j.biochi.2008.10.012
167. Reyniers, E., Martin, J. J., Cras, P., Van Marck, E., Handig, I., Jorens, H. Z.,et al. (1999). Postmortem examination of two fragile X brothers with an FMR1 full mutation. Am. J. Med. Genet. 84, 245-249. doi: 10.1002/(SICI)1096-8628(19990528)84:3<245::AID-AJMG16>3.0.CO;2-U
168. Reyniers, E., Vits, L., De Boulle, K., Van Roy, B., Van Velzen, D., De Graaff, E.,et al. (1993). The full mutation in the FMR-1 gene of male fragile X patients is absent in their sperm. Nat. Genet. 4, 143-146. doi: 10.1038/ng0693-143
169. Rodriguez-Revenga, L., Madrigal, I., Pagonabarraga, J., Xuncla, M., Badenas, C., Kulisevsky, J.,et al. (2009). Penetrance of FMR1 premutation associated pathologies in fragile X syndrome families. Eur. J. Hum. Genet. 17, 1359-1362. doi: 10.1038/ejhg.2009.51
170. Rohr, J., Allen, E. G., Charen, K., Giles, J., He, W., Dominguez, C.,et al. (2008). Anti-Mullerian hormone indicates early ovarian decline in fragile X mental retardation (FMR1) premutation carriers: a preliminary study. Hum. Reprod. 23, 1220-1225. doi: 10.1093/humrep/den050
171. Rougemaille, M., Braun, S., Coyle, S., Dumesic, P. A., Garcia, J. F., Isaac, R. S.,et al. (2012). Ers1 links HP1 to RNAi. Proc. Natl. Acad. Sci. U.S.A. 109, 11258-11263. doi: 10.1073/pnas.1204947109
172. Rousseau, F., Heitz, D., Biancalana, V., Blumenfeld, S., Kretz, C., Boue, J.,et al. (1991). Direct diagnosis by DNA analysis of the fragile X syndrome of mental retardation. N. Engl. J. Med. 325, 1673-1681. doi: 10.1056/NEJM199112123252401
173. Rousseau, F., Robb, L. J., Rouillard, P., and Der Kaloustian, V. M. (1994). No mental retardation in a man with 40% abnormal methylation at the FMR-1 locus and transmission of sperm cell mutations as permutations. Hum. Mol. Genet. 3, 927-930. doi: 10.1093/hmg/3.6.927
174. Santa Maria, L., Pugin, A., Alliende, M., Aliaga, S., Curotto, B., Aravena, T.,et al. (2013). FXTAS in an unmethylated mosaic male with fragile X syndrome from Chile. Clin. Genet. doi: 10.1111/cge.12278 [Epub ahead of print].
175. Santos, F., Hendrich, B., Reik, W., and Dean, W. (2002). Dynamic reprogramming of DNA methylation in the early mouse embryo. Dev. Biol. 241, 172-182. doi: 10.1006/dbio.2001.0501
176. Savouret, C., Brisson, E., Essers, J., Kanaar, R., Pastink, A., Te Riele, H.,et al. (2003). CTG repeat instability and size variation timing in DNA repair-deficient mice. EMBO J. 22, 2264-2273. doi: 10.1093/emboj/cdg202
177. Schmucker, B., and Seidel, J. (1999). Mosaicism for a full mutation and a normal size allele in two fragile X males. Am. J. Med. Genet. 84, 221-225. doi: 10.1002/(SICI)1096-8628(19990528)84:3<221::AID-AJMG11>3.0.CO;2-M
178. Sellier, C., Freyermuth, F., Tabet, R., Tran, T., He, F., Ruffenach, F.,et al. (2013). Sequestration of DROSHA and DGCR8 by expanded CGG RNA repeats alters microRNA processing in fragile X-associated tremor/ataxia syndrome. Cell Rep. 3, 869-880. doi: 10.1016/j.celrep.2013.02.004
179. Sellier, C., Rau, F., Liu, Y., Tassone, F., Hukema, R. K., Gattoni, R.,et al. (2010). Sam68 sequestration and partial loss of function are associated with splicing alterations in FXTAS patients. EMBO J. 29, 1248-1261. doi: 10.1038/emboj.2010.21
180. Seritan, A. L., Nguyen, D. V., Farias, S. T., Hinton, L., Grigsby, J., Bourgeois, J. A.,et al. (2008). Dementia in fragile X-associated tremor/ataxia syndrome (FXTAS): comparison with Alzheimer's disease. Am. J. Med. Genet. B Neuropsychiatr. Genet. 147B, 1138-1144. doi: 10.1002/ajmg.b.30732
181. Shapiro, L. R., Simensen, R. J., Wilmot, P. L., Fisch, G. S., Vibert, B. K., Fenwick, R. G.,et al. (1994). Asymmetry of methylation with FMR-1 full mutation in two 45,X/46,XX mosaic females associated with normal intellect. Am. J. Med. Genet. 51, 507-508. doi: 10.1002/ajmg.1320510443
182. Sherman, S. L. (2000). Premature ovarian failure in the fragile X syndrome. Am. J. Med. Genet. 97, 189-194. doi: 10.1002/1096-8628(200023)97:3<189::AID-AJMG1036>3.0.CO;2-J
183. Smith, S. S., Laayoun, A., Lingeman, R. G., Baker, D. J., and Riley, J. (1994). Hypermethylation of telomere-like foldbacks at codon 12 of the human c-Ha-ras gene and the trinucleotide repeat of the FMR-1 gene of fragile X. J. Mol. Biol. 243, 143-151. doi: 10.1006/jmbi.1994.1640
184. Spiro, C., Pelletier, R., Rolfsmeier, M. L., Dixon, M. J., Lahue, R. S., Gupta, G.,et al. (1999). Inhibition of FEN-1 processing by DNA secondary structure at trinucleotide repeats. Mol. Cell 4, 1079-1085. doi: 10.1016/S1097-2765(00)80236-1
185. Streuli, I., Fraisse, T., Ibecheole, V., Moix, I., Morris, M. A., and De Ziegler, D. (2009). Intermediate and premutation FMR1 alleles in women with occult primary ovarian insufficiency. Fertil. Steril. 92, 464-470. doi: 10.1016/j.fertnstert.2008.07.007
186. Sullivan, A. K., Marcus, M., Epstein, M. P., Allen, E. G., Anido, A. E., Paquin, J. J.,et al. (2005). Association of FMR1 repeat size with ovarian dysfunction. Hum. Reprod. 20, 402-412. doi: 10.1093/humrep/deh635
187. Sullivan, S. D., Welt, C., and Sherman, S. (2011). FMR1 and the continuum of primary ovarian insufficiency. Semin. Reprod. Med. 29, 299-307. doi: 10.1055/s-0031-1280915
188. Sun, Q., Csorba, T., Skourti-Stathaki, K., Proudfoot, N. J., and Dean, C. (2013). R-loop stabilization represses antisense transcription at the Arabidopsis FLC locus. Science 340, 619-621. doi: 10.1126/science.1234848
189. Sutcliffe, J. S., Nelson, D. L., Zhang, F., Pieretti, M., Caskey, C. T., Saxe, D.,et al. (1992). DNA methylation represses FMR-1 transcription in fragile X syndrome. Hum. Mol. Genet. 1, 397-400. doi: 10.1093/hmg/1.6.397
190. Sutherland, G. R., and Ashforth, P. L. (1979). X-linked mental retardation with macro-orchidism and the fragile site at Xq 27 or 28. Hum. Genet. 48, 117-120. doi: 10.1007/BF00273283
191. Swift, M., Morrell, D., Cromartie, E., Chamberlin, A. R., Skolnick, M. H., and Bishop, D. T. (1986). The incidence and gene frequency of ataxia-telangiectasia in the United States. Am. J. Hum. Genet. 39, 573-583.
192. Tabolacci, E., Moscato, U., Zalfa, F., Bagni, C., Chiurazzi, P., and Neri, G. (2008a). Epigenetic analysis reveals a euchromatic configuration in the FMR1 unmethylated full mutations. Eur. J. Hum. Genet. 16, 1487-1498. doi: 10.1038/ejhg.2008.130
193. Tabolacci, E., Pomponi, M. G., Pietrobono, R., Chiurazzi, P., and Neri, G. (2008b). A unique case of reversion to normal size of a maternal premutation FMR1 allele in a normal boy. Eur. J. Hum. Genet. 16, 209-214. doi: 10.1038/sj.ejhg.5201949
194. Tachibana, M., Matsumura, Y., Fukuda, M., Kimura, H., and Shinkai, Y. (2008). G9a/GLP complexes independently mediate H3K9 and DNA methylation to silence transcription. EMBO J. 27, 2681-2690. doi: 10.1038/emboj.2008.192
195. Tassone, F., Beilina, A., Carosi, C., Albertosi, S., Bagni, C., Li, L.,et al. (2007). Elevated FMR1 mRNA in premutation carriers is due to increased transcription. RNA 13, 555-562. doi: 10.1261/rna.280807
196. Tassone, F., and Hagerman, R. (2012). The fragile X-associated tremor ataxia syndrome. Results Probl. Cell Differ. 54, 337-357. doi: 10.1007/978-3-642-21649-7_18
197. Tassone, F., Hagerman, R. J., Chamberlain, W. D., and Hagerman, P. J. (2000a). Transcription of the FMR1 gene in individuals with fragile X syndrome. Am. J. Med. Genet. 97, 195-203. doi: 10.1002/1096-8628(200023)97:3<195::AID-AJMG1037>3.0.CO;2-R
198. Tassone, F., Hagerman, R. J., Loesch, D. Z., Lachiewicz, A., Taylor, A. K., and Hagerman, P. J. (2000b). Fragile X males with unmethylated, full mutation trinucleotide repeat expansions have elevated levels of FMR1 messenger RNA. Am. J. Med. Genet. 94, 232-236. doi: 10.1002/1096-8628(20000918)94:3<232::AID-AJMG9>3.0.CO;2-H
199. Tassone, F., Hagerman, R. J., Taylor, A. K., Gane, L. W., Godfrey, T. E., and Hagerman, P. J. (2000c). Elevated levels of FMR1 mRNA in carrier males: a new mechanism of involvement in the fragile-X syndrome. Am. J. Hum. Genet. 66, 6-15. doi: 10.1086/302720
200. Tassone, F., Hagerman, R. J., Ikle, D. N., Dyer, P. N., Lampe, M., Willemsen, R.,et al. (1999). FMRP expression as a potential prognostic indicator in fragile X syndrome. Am. J. Med. Genet. 84, 250-261. doi: 10.1002/(SICI)1096-8628(19990528)84:3<250::AID-AJMG17>3.0.CO;2-4
201. Tassone, F., Iwahashi, C., and Hagerman, P. J. (2004). FMR1 RNA within the intranuclear inclusions of fragile X-associated tremor/ataxia syndrome (FXTAS). RNA Biol. 1, 103-105. doi: 10.4161/rna.1.2.1035
202. Taylor, A. K., Tassone, F., Dyer, P. N., Hersch, S. M., Harris, J. B., Greenough, W. T.,et al. (1999). Tissue heterogeneity of the FMR1 mutation in a high-functioning male with fragile X syndrome. Am. J. Med. Genet. 84, 233-239. doi: 10.1002/(SICI)1096-8628(19990528)84:3<233::AID-AJMG14>3.0.CO;2-6
203. Tejada, M. I., Garcia-Alegria, E., Bilbao, A., Martinez-Bouzas, C., Beristain, E., Poch, M.,et al. (2008). Analysis of the molecular parameters that could predict the risk of manifesting premature ovarian failure in female premutation carriers of fragile X syndrome. Menopause 15, 945-949. doi: 10.1097/gme.0b013e3181647762
204. Tejada, M. I., Mornet, E., Tizzano, E., Molina, M., Baiget, M., and Boue, A. (1994). Identification by molecular diagnosis of mosaic Turner's syndrome in an obligate carrier female for fragile X syndrome. J. Med. Genet. 31, 76-78. doi: 10.1136/jmg.31.1.76
205. Todd, P. K., Oh, S. Y., Krans, A., He, F., Sellier, C., Frazer, M.,et al. (2013). CGG repeat-associated translation mediates neurodegeneration in fragile X tremor ataxia syndrome. Neuron 78, 440-455. doi: 10.1016/j.neuron.2013.03.026
206. Todd, P. K., Oh, S. Y., Krans, A., Pandey, U. B., Di Prospero, N. A., Min, K. T.,et al. (2010). Histone deacetylases suppress CGG repeat-induced neurodegeneration via transcriptional silencing in models of fragile X tremor ataxia syndrome. PLoS Genet. 6:e1001240. doi: 10.1371/journal.pgen.1001240
207. Todorov, T., Todorova, A., Kirov, A., Dimitrov, B., Carvalho, R., Nygren, A. O.,et al. (2009). Fragile X mosaic male full mutation/normal allele detected by PCR/MS-MLPA. BMJ Case Rep. 2009, bcr06.2008.0139. doi: 10.1136/bcr.06.2008.0139
208. Tome, S., Manley, K., Simard, J. P., Clark, G. W., Slean, M. M., Swami, M.,et al. (2013). MSH3 polymorphisms and protein levels affect CAG repeat instability in Huntington's disease mice. PLoS Genet. 9:e1003280. doi: 10.1371/journal.pgen.1003280
209. Trost, N., Cook, M., Hammersley, E., Bui, M. Q., Brotchie, P., Burgess, T.,et al. (2013). White matter changes in patients with Parkinson's disease carrying small CGG expansion FMR1 alleles: a pilot study. Neurodegener. Dis. doi: 10.1159/000356190 [Epub ahead of print].
210. Turner, G., Daniel, A., and Frost, M. (1980). X-linked mental retardation, macro-orchidism, and the Xq27 fragile site. J. Pediatr. 96, 837-841. doi: 10.1016/S0022-3476(80)80552-X
211. Usdin, K. (1998). NGG-triplet repeats form similar intrastrand structures: implications for the triplet expansion diseases. Nucleic Acids Res. 26, 4078-4085. doi: 10.1093/nar/26.17.4078
212. Usdin, K. (2008). The biological effects of simple tandem repeats: lessons from the repeat expansion diseases. Genome Res. 18, 1011-1019. doi: 10.1101/gr.070409.107
213. Usdin, K., and Woodford, K. J. (1995). CGG repeats associated with DNA instability and chromosome fragility form structures that block DNA synthesis in vitro. Nucleic Acids Res. 23, 4202-4209. doi: 10.1093/nar/23.20.4202
214. Vaisanen, M. L., Haataja, R., and Leisti, J. (1996). Decrease in the CGGn trinucleotide repeat mutation of the fragile X syndrome to normal size range during paternal transmission. Am. J. Hum. Genet. 59, 540-546.
215. van den Broek, W. J., Nelen, M. R., Wansink, D. G., Coerwinkel, M. M., Te Riele, H., Groenen, P. J.,et al. (2002). Somatic expansion behaviour of the (CTG)n repeat in myotonic dystrophy knock-in mice is differentially affected by Msh3 and Msh6 mismatch-repair proteins. Hum. Mol. Genet. 11, 191-198. doi: 10.1093/hmg/11.2.191
216. Verkerk, A. J., Pieretti, M., Sutcliffe, J. S., Fu, Y. H., Kuhl, D. P., Pizzuti, A.,et al. (1991). Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell 65, 905-914. doi: 10.1016/0092-8674(91)90397-H
217. Vire, E., Brenner, C., Deplus, R., Blanchon, L., Fraga, M., Didelot, C.,et al. (2006). The Polycomb group protein EZH2 directly controls DNA methylation. Nature 439, 871-874. doi: 10.1038/nature04431
218. Voineagu, I., Surka, C. F., Shishkin, A. A., Krasilnikova, M. M., and Mirkin, S. M. (2009). Replisome stalling and stabilization at CGG repeats, which are responsible for chromosomal fragility. Nat. Struct. Mol. Biol. 16, 226-228. doi: 10.1038/nsmb.1527
219. Volpe, T. A., Kidner, C., Hall, I. M., Teng, G., Grewal, S. I., and Martienssen, R. A. (2002). Regulation of heterochromatic silencing and histone H3 lysine-9 methylation by RNAi. Science 297, 1833-1837. doi: 10.1126/science.1074973
220. Voorhuis, M., Onland-Moret, N. C., Fauser, B. C., Ploos Van Amstel, H. K., Van Der Schouw, Y. T., and Broekmans, F. J. (2013). The association of CGG repeats in the FMR1 gene and timing of natural menopause. Hum. Reprod. 28, 496-501. doi: 10.1093/humrep/des392
221. Wang, L. W., Berry-Kravis, E., and Hagerman, R. J. (2010). Fragile X: leading the way for targeted treatments in autism. Neurotherapeutics 7, 264-274. doi: 10.1016/j.nurt.2010.05.005
222. Wang, Y. H., Gellibolian, R., Shimizu, M., Wells, R. D., and Griffith, J. (1996). Long CCG triplet repeat blocks exclude nucleosomes: a possible mechanism for the nature of fragile sites in chromosomes. J. Mol. Biol. 263, 511-516. doi: 10.1006/jmbi.1996.0593
223. Webb, T. (1992). Delayed replication of Xq27 in individuals with the fragile X syndrome. Am. J. Med. Genet. 43, 1057-1062. doi: 10.1002/ajmg.1320430633
224. Weisman-Shomer, P., Cohen, E., and Fry, M. (2000). Interruption of the fragile X syndrome expanded sequence d(CGG)n by interspersed d(AGG) trinucleotides diminishes the formation and stability of d(CGG)n tetrahelical structures. Nucleic Acids Res. 28, 1535-1541. doi: 10.1093/nar/28.7.1535
225. Welt, C. K., Smith, P. C., and Taylor, A. E. (2004). Evidence of early ovarian aging in fragile X premutation carriers. J. Clin. Endocrinol. Metab. 89, 4569-4574. doi: 10.1210/jc.2004-0347
226. Wilkin, H., Tuohy, J., and Theewis, W. (2000). Prenatal diagnosis of fragile X and Turner mosaicism in a 12-week fetus. Prenat. Diagn. 20, 854-855. doi: 10.1002/1097-0223(200010)20:10<854::AID-PD928>3.0.CO;2-1
227. Willemsen, R., Bontekoe, C. J., Severijnen, L. A., and Oostra, B. A. (2002). Timing of the absence of FMR1 expression in full mutation chorionic villi. Hum. Genet. 110, 601-605. doi: 10.1007/s00439-002-0723-5
228. Wittenberger, M. D., Hagerman, R. J., Sherman, S. L., Mcconkie-Rosell, A., Welt, C. K., Rebar, R. W.,et al. (2007). The FMR1 premutation and reproduction. Fertil. Steril. 87, 456-465. doi: 10.1016/j.fertnstert.2006.09.004
229. Wohrle, D., Salat, U., Glaser, D., Mucke, J., Meisel-Stosiek, M., Schindler, D.,et al. (1998). Unusual mutations in high functioning fragile X males: apparent instability of expanded unmethylated CGG repeats. J. Med. Genet. 35, 103-111. doi: 10.1136/jmg.35.2.103
230. Wohrle, D., Salat, U., Hameister, H., Vogel, W., and Steinbach, P. (2001). Demethylation, reactivation, and destabilization of human fragile X full-mutation alleles in mouse embryocarcinoma cells. Am. J. Hum. Genet. 69, 504-515. doi: 10.1086/322739
231. Yrigollen, C. M., Durbin-Johnson, B., Gane, L., Nelson, D. L., Hagerman, R., Hagerman, P. J.,et al. (2012). AGG interruptions within the maternal FMR1 gene reduce the risk of offspring with fragile X syndrome. Genet. Med. 14, 729-736. doi: 10.1038/gim.2012.34
232. Yu, A., Barron, M. D., Romero, R. M., Christy, M., Gold, B., Dai, J.,et al. (1997). At physiological pH, d(CCG)15 forms a hairpin containing protonated cytosines and a distorted helix. Biochemistry 36, 3687-3699. doi: 10.1021/bi9625410
233. Yudkin, D., Hayward, B. E., Aladjem, M. I., Kumari, D., and Usdin, K. (2014). Chromosome fragility and the abnormal replication of the FMR1 locus in Fragile X syndrome. Hum. Mol. Genet. 23, 2940-2952. doi: 10.1093/hmg/ddu006
234. Zhao, X.-N., and Usdin, K. (2014). Gender and cell-type specific effects of the transcription coupled repair protein, ERCC6/CSB, on repeat expansion in a mouse model of the Fragile X-related disorders. Hum. Mutat. 35, 341-349. doi: 10.1002/humu.22495
235. Zhong, N., Ju, W., Pietrofesa, J., Wang, D., Dobkin, C., and Brown, W. T. (1996). Fragile X "gray zone" alleles: AGG patterns, expansion risks, and associated haplotypes. Am. J. Med. Genet. 64, 261-265. doi: 10.1002/(SICI)1096-8628(19960809)64:2<261::AID-AJMG5>3.0.CO;2-X